Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / SPONSORED ADS
-
Number of holders
-
291
-
Total 13F shares, excl. options
-
108,743,491
-
Shares change
-
+2,522,011
-
Total reported value, excl. options
-
$1,978,272,193
-
Value change
-
+$47,411,066
-
Put/Call ratio
-
113%
-
Number of buys
-
109
-
Number of sells
-
-136
-
Price
-
$18.20
Significant Holders of TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) as of Q4 2020
355 filings reported holding TAK - TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS as of Q4 2020.
TAKEDA PHARMACEUTICAL CO LTD - SPONSORED ADS (TAK) has 291 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 108,743,491 shares
.
Largest 10 shareholders include GLENVIEW CAPITAL MANAGEMENT, LLC (15,260,512 shares), PAULSON & CO. INC. (11,295,846 shares), ARK Investment Management LLC (8,618,165 shares), Adelphi Capital LLP (7,584,930 shares), RENAISSANCE TECHNOLOGIES LLC (5,578,700 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,362,644 shares), NORTHERN TRUST CORP (4,379,029 shares), MACQUARIE GROUP LTD (4,264,775 shares), Parametric Portfolio Associates LLC (3,518,126 shares), and Mondrian Investment Partners LTD (3,274,660 shares).
This table shows the top 291 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.